Additionally, researcher verified that hydroxysafflor yellow A (HSYA) treated traumatic brain injury (TBI) mice mainly through affecting the functions of blood vessels, increased brain microvessel density and the expression of angiogenic marker proteins VEGFA and CD34 (61). This evidence concerns the gene CD34 and brain injury.